Lyfovit

Lyfovit is a nutritional supplement combining a standard multivitamin blend with the essential amino acid L-lysine. It is indicated for:

• General nutritional supplementation — to help meet daily requirements of vitamins A, D, E, C, B-complex vitamins, and folic acid when dietary intake is insufficient (established use).
• Supportive care for poor appetite and inadequate growth in children — Lyfovit is commonly marketed and used as an adjunct to help support appetite and physical development in children with poor dietary intake (adjunct/traditional use; evidence for a specific appetite-stimulant or growth-promoting effect from the added L-lysine is limited and not robustly established in controlled trials).
• Supporting calcium absorption and general metabolic/energy needs during periods of increased nutritional demand, such as convalescence after illness, in underweight individuals, or in those with restricted diets (adjunct use).

Lyfovit is not a treatment for a diagnosed vitamin or mineral deficiency disease, malnutrition, or a specific growth disorder — such conditions require proper medical evaluation and targeted treatment. It is also not a substitute for a balanced diet.

A typical tablet formulation of Multivitamin with L-Lysine contains (per tablet, representative composition — check the specific product label for exact strengths):

• L-Lysine (as L-Lysine Hydrochloride/USP) — 50 mg
• Vitamin A — 1500 IU
• Vitamin D3 (Cholecalciferol) — 100 IU
• Vitamin E — 10 IU
• Vitamin B1 (Thiamine) — 0.25 mg
• Vitamin B2 (Riboflavin) — 0.25 mg
• Vitamin B6 (Pyridoxine) — 0.25 mg
• Vitamin B12 (Cyanocobalamin) — 2 mcg
• Vitamin C (Ascorbic Acid) — 50 mg
• Nicotinamide — 2.5 mg
• Folic Acid — 0.25 mg

Exact quantities may vary slightly between manufacturers and dosage forms (tablet/syrup/drops).

Lyfovit is a combination nutritional supplement product that pairs a multivitamin blend (vitamins A, D, E, C, the B-complex vitamins, nicotinamide, and folic acid) with L-lysine, an essential amino acid that the body cannot synthesize and must obtain from the diet.

L-lysine plays a role in protein synthesis, collagen formation, and calcium absorption. When combined with a balanced multivitamin, this product is intended to support overall nutritional status, particularly in individuals — including children — with reduced dietary intake, poor appetite, or increased nutritional needs.

Lyfovit is available in Bangladesh as an oral tablet (and in some markets as a syrup/drops for pediatric use), and is used as a dietary supplement rather than as a treatment for a specific disease.

Lyfovit belongs to the therapeutic class of vitamin and amino-acid combination nutritional supplements (specific combined vitamin preparations with added amino acid), used for general nutritional support.

Multivitamin with L-Lysine works through the combined physiological roles of its vitamin and amino acid components:

• L-Lysine is an essential amino acid required for protein synthesis, including structural proteins such as collagen. It is also believed to play a role in intestinal calcium absorption and renal calcium retention, and has been studied (with limited robust evidence) for a possible role in appetite regulation.
• Vitamin A supports vision, immune function, and epithelial tissue integrity.
• Vitamin D3 promotes intestinal calcium and phosphate absorption, supporting bone mineralization.
• Vitamin E acts as an antioxidant, protecting cell membranes from oxidative damage.
• B-complex vitamins (B1, B2, B6, B12) and Nicotinamide function as coenzymes in carbohydrate, fat, and protein metabolism and support nervous system function.
• Vitamin C supports collagen synthesis, immune function, and acts as an antioxidant; it also enhances absorption of dietary iron.
• Folic Acid is required for DNA synthesis and red blood cell formation.

Together, these components are intended to correct or prevent mild nutritional insufficiencies and support normal growth and metabolic processes when taken as directed.

Lyfovit is administered orally. Tablets should be swallowed with water, preferably taken with or after meals to reduce the likelihood of mild stomach upset. Syrup or drop formulations, where available, should be measured using the measuring device provided with the product and given as directed for the child's age.

Clinically significant interactions with Lyfovit are uncommon at recommended supplemental doses, but the following should be noted:

• High-dose calcium or additional vitamin D supplements: Concurrent use with other vitamin D–containing products may increase the risk of hypervitaminosis D and hypercalcemia if total intake becomes excessive.
• Other multivitamin or single-vitamin products: Taking Lyfovit together with additional unsupervised multivitamin or high-dose single-vitamin supplements (especially fat-soluble vitamins A, D, E) may increase the risk of cumulative vitamin toxicity; avoid duplicating vitamin sources unless a physician advises otherwise.
• Calcium supplements/dairy with L-lysine: No clinically significant adverse interaction is established; L-lysine may theoretically support calcium absorption.
• Tetracycline-class antibiotics: Divalent/trivalent mineral content in some multivitamin formulations can reduce absorption of tetracyclines if taken simultaneously; if such antibiotics are prescribed, they are generally best separated in timing from multivitamin doses on a physician's or pharmacist's advice.

Lyfovit is generally well tolerated when taken at the recommended dose. Reported side effects are uncommon and usually mild:

• Mild gastrointestinal upset — nausea, stomach discomfort, or diarrhea, particularly if taken on an empty stomach or at doses exceeding the recommendation.
• Rare hypersensitivity reactions (skin rash, itching) in individuals sensitive to a specific component.

Symptoms of excessive intake (see Overdose) can occur if the recommended dose is significantly and persistently exceeded.

Specific controlled safety data for Lyfovit in pregnancy and lactation are limited. As with any nutritional supplement, Lyfovit should be used during pregnancy or breastfeeding only if clearly needed and after consulting a physician, who can weigh the potential nutritional benefit against any potential risk and ensure the dose does not lead to excessive intake of fat-soluble vitamins (A, D, E), which can be harmful in high amounts during pregnancy. Pregnant and breastfeeding women should generally rely on prenatal vitamins specifically formulated and prescribed for this purpose rather than substituting Lyfovit without medical advice.

The following precautions apply to the use of Lyfovit:

• Do not exceed the recommended daily dose; excessive intake of fat-soluble vitamins (A, D, E) contained in Lyfovit can accumulate in the body and cause toxicity over time.
• Avoid taking additional unsupervised high-dose vitamin or mineral supplements while using Lyfovit, as this can lead to cumulative overdosing (see Interactions).
• Lyfovit is not a substitute for a balanced, varied diet, and it does not treat a diagnosed specific nutritional deficiency, malnutrition, or a medically significant growth or appetite disorder — such conditions require proper medical evaluation.
• Evidence supporting a specific appetite-stimulating or growth-promoting benefit from the added L-lysine component is limited; Lyfovit should be viewed as general nutritional support rather than a guaranteed remedy for poor appetite or slow growth.
• Use with caution in patients with kidney disease, as impaired excretion may increase the risk of accumulation of certain vitamins and amino acids; consult a physician first.
• Keep out of reach of children — accidental ingestion of a large quantity (especially of iron-containing multivitamin variants, if present) can be dangerous.

Significantly exceeding the recommended dose of Lyfovit over time may lead to symptoms of vitamin toxicity, such as headache, nausea, vomiting, abdominal pain, or (with chronic excessive intake of fat-soluble vitamins) more serious effects. High doses of L-lysine may rarely cause gastrointestinal upset. If an overdose is suspected, especially in a child, seek immediate medical attention or contact a poison control center/emergency services; do not attempt to manage a suspected overdose at home without professional guidance.

Store below 25°C, protected from light and moisture. Keep the container tightly closed after use, and keep out of reach of children.

Children: Lyfovit is commonly used in children aged 1 year and above as a nutritional supplement, with dose adjusted by age and physical condition; use in infants under 1 year is not recommended unless specifically directed by a physician (see Pediatric Uses).

Elderly: No specific dose adjustment is generally required in elderly individuals, but underlying kidney or liver conditions should be considered, and a physician should be consulted before use.

Renal impairment: Use with caution; reduced clearance may increase the risk of accumulation of certain vitamins. Consult a physician.

Hepatic impairment: No well-established dose adjustment is defined; use with general caution and medical advice, since the liver is involved in metabolism and storage of fat-soluble vitamins.

Lyfovit is typically used for a limited course (commonly a few weeks to a few months) to support nutritional status during a period of poor appetite, illness recovery, or increased nutritional need, rather than for indefinite continuous use. Prolonged use beyond a few months should be reassessed with a physician to confirm ongoing need and to avoid unnecessary long-term vitamin accumulation.

Multivitamin with L-Lysine falls under the drug class of multivitamin and amino-acid combination nutritional supplements.

The vitamin components of Multivitamin with L-Lysine act as essential cofactors and antioxidants supporting metabolism, immune function, vision, bone mineralization, and red blood cell formation, while the L-lysine component supports protein synthesis, collagen formation, and calcium absorption. Together they act to correct or prevent mild nutritional insufficiency rather than through a single pharmacological mechanism.

Lyfovit is commonly used in children aged 1 year and above as a nutritional supplement to support general nutrition and appetite, at a dose of 1–3 tablets daily adjusted by age and physical condition (or the equivalent syrup/drop dose for younger children who cannot take tablets). Use in infants below 1 year is not recommended unless specifically advised by a physician, as safety and dosing in this age group are not well established. Lyfovit does not replace medical evaluation for a child with persistent poor appetite, failure to thrive, or a suspected specific deficiency, which requires pediatric assessment.